Colgate-Palmolive Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CL research report →
Range $79 – $102
Price Chart
About the company
Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.
- CEO
- Noel R. Wallace
- IPO
- 1973
- Employees
- 33,600
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on CL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $73.42B
- P/E
- 35.35
- Fwd P/E
- 24.09
- PEG
- -1.31
- P/S
- 3.53
- P/B
- 507.39
- EV/EBITDA
- 20.58
- Div Yield
- 2.29%
- Gross Margin
- 60.06%
- Op Margin
- 21.21%
- Net Margin
- 10.04%
- ROE
- 475.13%
- ROIC
- 30.42%
Latest fiscal year · YoY change
- Revenue
- $20.38B+1.4%
- Gross Profit
- $12.25B+1.2%
- Op Income
- $4.35B
- Net Income
- $2.13B-26.2%
- EPS
- $2.64-25.2%
- OCF Growth
- +2.2%
- FCF Growth
- +2.5%
- 52W High
- $99.33
- 52W Low
- $74.55
- 50D MA
- $90.34
- 200D MA
- $85.49
- Beta
- 0.32
- RSI (14)
- 50
- Avg Volume
- 5.23M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the CL Q1 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 93.8%
- Shares Outstanding
- 800.19M
- Float Shares
- 750.71M
of shares held by institutions
1,999 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CL, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Ro KhannaHouse · CA17 | Buy | Jun 2, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 13, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| John BoozmanSenate · AR | Sell | Oct 9, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Oct 7, 25 | Filing → |
| Lisa McClainHouse · MI09 | Sell | Sep 11, 25 | Filing → |
| Rick LarsenHouse · WA02 | Sell | Oct 6, 25 | Filing → |
| Tim MooreHouse · NC14 | Sell | Sep 10, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Sep 25, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Sep 29, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Sep 5, 25 | Filing → |
| Lisa McClainHouse · MI09 | Buy | Aug 13, 25 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Aug 26, 25 | Filing → |
| Ritchie TorresHouse · NY15 | Sell | Jul 11, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 83.95M | ▲ 1.03M |
| Blackrock, Inc. | 72.64M | ▲ 2.17M |
| State Street Corp | 47.72M | ▼ 755.30K |
| Price T Rowe Associates Inc | 33.73M | ▲ 2.54M |
| Geode Capital Management, LLC | 22.90M | ▲ 796.39K |
| Morgan Stanley | 20.88M | ▲ 1.64M |
| Bank Of New York Mellon Corp | 12.52M | ▲ 7.93M |
| Deutsche Bank AG\ | 11.93M | ▲ 1.08M |
| Norges Bank | 10.90M | ▲ 10.90M |
| Goldman Sachs Group Inc | 9.48M | ▲ 3.98M |
| Fmr LLC | 9.01M | ▲ 887.43K |
| Northern Trust Corp | 8.68M | ▼ 15.77K |
Held by 1,567 ETFs
Biggest fund positions in CL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | NORRINGTON LORRIE M | other | 293 |
| Jul 1, 26 | Newman Brian | other | 209 |
| Jul 1, 26 | BILBREY JOHN P | other | 265 |
| Jun 16, 26 | GRANT SHANE | other | 23,347 |
| Jun 1, 26 | Fishbone Betsy | other | 0 |
| Jun 1, 26 | Fishbone Betsy | other | 0 |
| Jun 1, 26 | Fishbone Betsy | other | 0 |
| Jun 1, 26 | Fishbone Betsy | other | 19,012 |
| Jun 1, 26 | Fishbone Betsy | other | 9,944 |
| Jun 1, 26 | Fishbone Betsy | other | 16,612 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CL coverage
Recent articles, reports, and earnings notes.
Want a deeper read on CL?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Boston Common Asset Management LLC Has $21.32 Million Stock Position in Colgate-Palmolive Company $CL
defenseworld.net · Jul 20
Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 – 8:30 a.m. ET
businesswire.com · Jul 17
4 Dividend Kings Are Crushing the S&P 500 in 2026 and Still Have Big Upside Potential
247wallst.com · Jul 14
Stock Of A Great Dividend King Jumps 24%
247wallst.com · Jul 10
Meet the Dividend King Stock That's Up 20% in 2026. Here's Why It Can Continue Outperforming the S&P 500 and Nasdaq-100 in the Second Half.
fool.com · Jul 7
Procter & Gamble vs Colgate-Palmolive: Two Consumer Giants, Two Strategies, One Invests, Other Optimizes
247wallst.com · Jul 4
Meet the Dividend King With a 64-Year Streak That Wall Street Is Sleeping On
fool.com · Jul 3
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
zacks.com · Jul 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on CL?